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Adenosine deaminases acting on RNA (ADARs) are
involved in RNA editing that converts adenosine
residues to inosine specifically in double-stranded
RNAs. In this study, we investigated the interaction
of the RNA editing mechanism with the RNA interfer-
ence (RNAi) machinery and found that ADAR1 forms
a complex with Dicer through direct protein-protein
interaction. Most importantly, ADAR1 increases the
maximum rate (Vmax) of pre-microRNA (miRNA)
cleavage by Dicer and facilitates loading of miRNA
onto RNA-induced silencing complexes, identifying
a new role of ADAR1 in miRNA processing and
RNAi mechanisms. ADAR1 differentiates its func-
tions in RNA editing and RNAi by the formation of
either ADAR1/ADAR1 homodimer or Dicer/ADAR1
heterodimer complexes, respectively. As expected,
the expression of miRNAs is globally inhibited in
ADAR1/ mouse embryos, which, in turn, alters
the expression of their target genes and might
contribute to their embryonic lethal phenotype.
INTRODUCTION
Adenosine deaminases acting on RNA (ADARs) are the enzymes
involved in one type of RNA editing that converts adenosine res-
idues into inosine (A-to-I RNA editing) in double-stranded RNAs
(dsRNAs). The translation machinery reads inosine as guano-
sine, leading to the recoding of a relatively small number of
neurotransmitter and ion channel genes and diversification of
their functions (Hood and Emeson, 2012). However, A-to-I edit-
ing occurs most frequently in noncoding regions that contain re-
petitive elements such as Alu and LINE (Ramaswami et al., 2012).
The biological significance of repetitive RNA editing is largely un-
known. Three ADAR gene familymembers (ADAR1–3) are known
in vertebrates.Members of the ADAR gene family share common
structural features, such as the presence of multiple dsRNA
binding domains (dsRBDs) and a separate deaminase domain.
Three repeats of dsRBD are present in ADAR1, whereas onlytwo repeats are found in ADAR2 and ADAR3 (Nishikura, 2010).
The inactivation of ADAR1 leads to an embryonic lethal pheno-
type due to widespread apoptosis (Hartner et al., 2004; Wang
et al., 2004), indicating the absolute requirement of ADAR1 for
life. However, the mechanism that underlies the ADAR1/
mouse phenotype is unknown.
The RNase III gene family members Drosha and Dicer are key
components of the microRNA (miRNA) processing machinery
(Krol et al., 2010). In the nucleus, Drosha with a dsRNA-binding
protein DGCR8 cleaves primary transcripts of miRNA genes
(pri-miRNAs) to produce intermediate precursors, pre-miRNAs.
Once exported to the cytoplasm, pre-miRNAs are cleaved by
Dicer, releasing 21–24 nt mature miRNAs (Krol et al., 2010). A
separate dsRNA-binding protein, HIV-1 TAR RNA-binding pro-
tein (TRBP), binds to Dicer and enhances the Dicer activity
(Chakravarthy et al., 2010). The Dicer/TRBP complex also acts
as the platform for RNA-induced silencing complex (RISC)
assembly by recruiting Ago2 (Chendrimada et al., 2005), which
is the catalytic engine to execute the RISC-mediated silencing
either by translational suppression or degradation of target
mRNAs (Liu et al., 2004; Meister et al., 2004). The RISC consist-
ing of Dicer, TRBP, and Ago2 is the core miRNA-mediated
silencing machinery that couples the miRNA processing and
silencing steps (Gregory et al., 2005).
RNA interference (RNAi)-dependent endogenous short RNAs
(endo-siRNA) derived from loci enriched for inverted repeats
and transposons are dramatically upregulated in ADAR null
mutant worms, indicating that A-to-I RNA editing of dsRNA
regions of transcripts derived from these loci inhibits their entry
into the RNAi silencing pathway (Wu et al., 2011). The A-to-I
RNA editing mechanism appears to compete for shared dsRNA
substrates with the RNAi machinery and inhibit synthesis of
endo-siRNAs (Wu et al., 2011). Furthermore, certain pri-miRNAs
are subject to A-to-I RNA editing. Editing of pri-miRNAs could
inhibit their processing (Kawahara et al., 2007a, 2008; Yang
et al., 2006), suppress RISC loading (Iizasa et al., 2010), or
lead to silencing of a different set of target genes by the edited
miRNAs (Kawahara et al., 2007b).
With these recent studies implicating an antagonistic interac-
tion of A-to-I RNA editing and RNAi pathways, we investi-
gated the interaction of ADAR1 with the RISC component
proteins. We found that ADAR1 interacts directly with Dicer inCell 153, 575–589, April 25, 2013 ª2013 Elsevier Inc. 575
Figure 1. ADAR1 Interacts with Dicer in an RNA-Binding-Independent Manner
(A) Pull-down products of FLAG-tagged RISC member proteins and reciprocal pull-down of FLAG-tagged ADAR1 (F-ADAR1p110) purified from HEK293 cell
extracts. Cytoplasmic extract (20 mg) and FLAG-IP peak eluate (15 ml) were examined by immunoblotting analysis. Amock FLAG-IP conductedwith untransfected
HEK293 cells was used to monitor the background levels of protein that may associate with the FLAG antibody resin (right panels). See also Figure S1.
(B) F-Dicer IP products fractionated by Superose 6 gel filtration column chromatography were analyzed by immunoblotting. The positions of the molecular mass
size markers are indicated by open arrowheads.
(C) Analysis of recombinant protein interactions in the Sf9 cell coinfection/copurification system. Various H-ADAR1 expression baculoviruses were coinfected
with F-Dicer, untagged TRBP, or F-Ago2 expression viruses. FLAG-IP isolated F-Dicer or F-Ago2, and immunoblotting determined their interaction with ADAR1.
TALON purifications isolated each H-ADAR1s, and immunoblotting determined their interaction with TRBP. See also Figure S1.
(legend continued on next page)
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an RNA-binding-independent manner and promotes processing
of small interfering RNAs (siRNAs) and miRNA, RISC loading of
miRNAs, and consequently silencing of target RNAs, revealing
a stimulative, instead of antagonistic, role of ADAR1 in RNAi. In
contrast to the requirement of homodimerization for the A-to-I
RNA editing activities of ADAR1 (Cho et al., 2003), one monomer
of ADAR1 binds to onemolecule of Dicer. ADAR1 thus acts as an
RNA editing enzyme or as a modulator of the RNAi machinery by
choosing its complex partner (i.e., ADAR1 itself or Dicer).
RESULTS
Interaction of ADAR1 with RISC Member Proteins
Two isoforms of ADAR1, a full-length interferon-inducible
ADAR1p150 and a shorter and constitutive ADAR1p110 trun-
cated at the N terminus, are known. A recent study indicates
that both ADAR1p150 and ADAR1p110 shuttle between the
nucleus and cytoplasm (Fritz et al., 2009). We confirmed that
both ADAR1p150 and p110 are located in the cytoplasm and
nucleus of human cell lines (Figure S1A available online).
ADAR2, known to localize mainly in the nucleus (Nishikura,
2010), and Dicer, known to localize in the cytoplasm (Krol
et al., 2010), served as controls for the quality of extraction
(Figure S1A).
A-to-I editing is considered to take placemainly in the nucleus,
and thus, the cytoplasmic distribution of ADAR1 suggests that
it may have functions separate from RNA editing, possibly in
the RNAi mechanism (Nishikura, 2006). We investigated the
interaction of the cytoplasmic ADAR1 with RISC component
proteins. The FLAG-epitope-tagged RISC proteins F-Dicer,
F-TRBP, and F-Ago2 were all individually purified from perma-
nently transformed HEK293 cell lines (Figure S1B). As expected,
endogenous RISC partner proteins were detected in F-Dicer,
F-TRBP, or F-Ago2 immunoprecipitation (IP) products (Fig-
ure 1A, left three columns). Most significantly, we found that
each FLAG-tagged RISCmember also pulled down endogenous
ADAR1p110 (Figure 1A). ADAR1p150 showed lesser interaction,
probably due to its low expression in HEK293 cells (Figure S1A).
The reciprocal F-ADAR1p110 IP experiment pulled down endog-
enous Dicer as well as TRBP and Ago2 to a lesser extent (Fig-
ure 1A, F-ADAR1p110 column). As a negative control, all FLAG
IP products were checked for interaction with endogenous
Tudor-SN, a protein reported to promote cleavage of hypere-
dited inosine containing dsRNAs (Scadden, 2005). We found
no interaction with Tudor-SN, confirming that the interaction
observed between ADAR1 and RISC proteins was specific (Fig-
ure 1A, bottom). Mock FLAG-IP experiments done with untrans-
fected HEK293 cells indicated that none of the endogenous
Dicer, TRBP, Ago2, or ADAR1 contaminated the mock purifica-
tion products (Figure 1A, Mock column), confirming that the
endogenous ADAR1 was specifically pulled down with RISC(D) Analysis of recombinant proteins purified from Sf9 cells triple infected with F
interaction with Ago2 mediated by Dicer. See also Figure S1.
(E) Analysis of recombinant proteins purified from Sf9 cells triple infected with F-D
immunoblotting determined its relative interaction with ADAR1 and TRBP. See a
(F) Analysis of recombinant proteins purified from Sf9 cells coinfected with F
determined its relative interaction with TRBP in the absence of ADAR1.member proteins. Similar F-ADAR2 IP experiments revealed no
interaction of ADAR2 with RISC proteins (data not shown). Size
exclusion chromatography of F-Dicer IP products revealed com-
plexes of 450 kDa size consisting of endogenous ADAR1p110
proteins (Figure 1B). The expected size of a complex consisting
of Dicer, ADAR1p110, and Ago2 is 450 kDa.
An RNA-Binding-Independent ADAR1 Interaction with
Dicer
Although the above experiments showed strong interaction of
ADAR1 with Dicer, they also showed lesser interaction with the
other RISC components. We therefore used a recombinant
baculovirus coinfection/copurification system to more precisely
characterize the interactions of ADAR1. A histidine affinity tag
(HAT)-tagged ADAR1 (H-ADAR1) expression virus was coin-
fected in Sf9 cells with an F-Dicer, F-Ago2, or untagged TRBP
expression virus, and the resulting complexes were purified by
FLAG IP or His-based TALON affinity chromatography. Each
type of affinity purification is completely specific for its cognate
epitope tag, as demonstrated by mock purification control
experiments (Figure S1C). We examined both ADAR1p110
and ADAR1p150 as well as a mutant ADAR1p150-EAA,
which is devoid of dsRNA binding due to point mutations
(KKxxK/EAxxA) introduced in each of the three dsRBDs (Val-
ente and Nishikura, 2007). Copurification of F-Dicer revealed
its interaction with all three forms of ADAR1, including the
ADAR1p150-EAA RNA-binding-defective mutant (Figure 1C,
left). The results established an RNA-binding-independent inter-
action of ADAR1 with Dicer. In contrast, the amount of TRBP
associated with H-ADAR1p110 or H-ADAR1p150 was substan-
tially lower and was virtually absent for H-ADAR1p150-EAA (Fig-
ure 1C, center). Finally, attempted copurification of F-Ago2 and
H-ADAR1 from coinfected Sf9 cells failed, indicating that they
do not interact directly with each other (Figure 1C, right). These
results demonstrate that the association of ADAR1 with TRBP
and Ago2 is indirect (i.e., bridged by Dicer and/or dsRNA). We
then purified ADAR1-associated complexes from Sf9 cells triple
infected with F-Dicer, H-ADAR1, and human influenza hemag-
glutinin-tagged Ago2 (HA-Ago2) expression viruses first by
TALON column and then by hemagglutinin IP. The FLAG IP pro-
cedure was not used for purification of these complexes. Never-
theless, the purified complex contained not only H-ADAR1 and
HA-Ago2 but also F-Dicer (Figure 1D), indicating that ADAR1
does form a triple complexwith Dicer and alsowith Ago2 through
its interaction with Dicer.
Finally, we examined whether the interaction of ADAR1 with
Dicer would preclude the interaction of TRBP with Dicer or vice
versa by analyzing FLAG-IP products copurified from Sf9 cells
triple infected with a 1:1:1 ratio of F-Dicer, H-ADAR1, and un-
tagged TRBP expression baculoviruses. ADAR1, including the
ADAR1p150-EAA RNA-binding-defective mutant, and TRBP-Dicer, H-ADAR1, and HA-Ago2. Immunoblotting determined ADAR1 indirect
icer, H-ADAR1, and untagged TRBP. FLAG purifications isolated F-Dicer, and
lso Figure S1.
-Dicer and TRBP. FLAG purifications isolated F-Dicer, and immunoblotting
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Figure 2. Domains Involved in the Dicer/ADAR1 Interaction
(A) The domain structures of human ADAR1, Dicer, and their deletion mutants are shown. The extent of Dicer/ADAR1 or ADAR1 homodimer interaction is
indicated as positive (+), weakly positive (±), or negative ().
(B) Mapping of the ADAR1 domain involved in the Dicer interaction. The full-length F-Dicer (bait) and full-length or one of the H-ADAR1p110 deletion mutants
(prey) were coinfected in Sf9 cells.
(legend continued on next page)
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were copurified with Dicer (Figure 1E). Because ADAR1 does not
interact with TRBP (Figure 1C, center), ADAR1 and TRBP
detected here in the F-Dicer pull-down products most likely
represent proteins present in two separate Dicer complexes:
one Dicer/ADAR1 and the other Dicer/TRBP. The results suggest
that the presence (coexpression) of ADAR1 did not exclude
formation of Dicer/TRBP complexes and the presence (coex-
pression) of TRBP did not exclude formation of Dicer/ADAR1
complexes. FLAG-Dicer pull-down of TRBP conducted in the
absence of ADAR1 (Figure 1F, coinfection) indicates that
perhaps slightly more (but not significantly more) TRBP proteins
can be complexed with Dicer if ADAR1 is not coexpressed as
compared to TRBP proteins pulled down in the presence of
ADAR1 (Figure 1E, triple infection). These results suggest that
there is no extreme affinity difference between ADAR1 and
TRBP for binding to Dicer.
The Domains Involved in the Dicer/ADAR1 Interaction
We examined the domains of ADAR1 and Dicer that are involved
in their protein-protein interaction. ADAR1p150 contains two
Z-DNA binding domains (a and b), three dsRBDs (dsRBD1,
dsRBD2, and dsRBD3), and a C-terminal deaminase domain.
The N terminus region containing the Z-DNA binding domain a
is missing in ADAR1p110 (Figure 2A). Dicer contains a DEAD-
box RNA helicase domain at the N terminus region followed by
DUF283 and PAZ domains, two catalytic RNase III domains,
and a dsRNA binding domain at the C terminus (Figure 2A).
The PAZ domain of Dicer likely binds to the 2 nt 30 overhangs
of miRNAs and siRNAs (Krol et al., 2010), whereas the DEAD-
box RNA helicase domain may be involved in an autoinhibition
mechanism (Ma et al., 2008).
Both ADAR1p150 and ADAR1p110 interacted with Dicer (Fig-
ure 1C), so ADAR1p110 was used for domain mapping analysis.
C-terminal deletion constructs of H-ADAR1p110 and C-terminal
deletion and N-terminal deletion constructs of F-Dicer were pre-
pared (Figure 2A). These ADAR1 and Dicer deletion constructs
were coinfectedwith the full-length partner construct in Sf9 cells.
The FLAG-IP purification is in general cleaner than that of TALON
purification. Therefore, we used the FLAG-IP procedure both for
identification of H-ADAR1 deletion mutants interacting with
F-Dicer (Figure 2B) and also for identification of F-Dicer deletion
mutants interacting with H-ADAR1 (Figure 2C). The full-length
F-Dicer (bait) was purified efficiently (Figure 2B, right top),
and the full-length H-ADAR1, H-ADAR1D1, and H-ADAR1D2
mutants, but not the H-ADAR1D3 and H-ADAR1D4 mutants
(prey), were pulled down by F-Dicer (Figure 2B, right bottom),
indicating that the second dsRBD (dsRBD2) of ADAR1 is
involved in the interaction with Dicer. All F-Dicer mutants (baits)
were purified efficiently via FLAG-IP (Figure 2C, right bottom).
Whereas the full-length H-ADAR1 was copurified and thus inter-(C) Mapping of the Dicer domain involved in the ADAR1 interaction. The full-length
were coinfected in Sf9 cells.
(B and C) FLAG-IP purification was done for isolation of F-Dicer/H-ADAR1 intera
(D) Mapping of the ADAR1 domain involved in the ADAR1 homodimer interaction.
deletion mutants (prey) were coinfected in Sf9 cells. FLAG-IP purification isolate
(B–D) FLAG-IP products were analyzed by immunoblotting. Left: Input cell extra
See also Figures S1, S5, and S6.acted robustly with the full-length F-Dicer and with the
F-DicerD1, F-DicerD2, and F-DicerD4 mutants, the F-DicerD3
mutant lacking the DUF283 domain and F-DicerDN1 lacking a
part of the DEAD-box RNA helicase domain displayed substan-
tially reduced (<4-fold) interaction with the H-ADAR1p110 (prey)
(Figure 2C, right top). Finally, the F-DicerDN2 mutant lacking
both DUF283 and DEAD-box RNA helicase domains lost its
interaction with ADAR1 completely (Figure 2C, right top), indi-
cating that both domains are involved in the interaction with
ADAR1.
We also determined the ADAR1 domains involved in the
ADAR1 homodimer interaction by using the full-length
F-ADAR1p110 (bait) and H-ADAR1p110 deletion mutants
(prey), which revealed that the third dsRBD (dsRBD3) is required
for the interaction (Figure 2D, right bottom). Together, our results
indicate that ADAR1 uses dsRBD2 and dsRBD3 differentially
for formation of the Dicer/ADAR1 heterodimer and the ADAR1
homodimer complexes, respectively.
ADAR1 Increases the Rate of miRNA and siRNA
Processing by Dicer
Although Dicer alone can cleave pre-miRNA to mature miRNA
(pre-miRNA dicing reaction), its catalytic activity is known to be
modulated by TRBP and PACT (Chendrimada et al., 2005; Haase
et al., 2005; Lee et al., 2006). For instance, TRBP binds to Dicer
and increases the maximum rate (Vmax) of the pre-miRNA dicing
reaction (Chakravarthy et al., 2010). Accordingly, we investi-
gated the effect of the ADAR1 interaction with Dicer on the
miRNA processing mechanism. We coexpressed F-Dicer with
H-ADAR1p110 or H-ADAR1p150 in Sf9 cells, and the F-Dicer/
H-ADAR1 complex was purified by consecutive TALON and
FLAG affinity chromatography (Figure S2A), which resulted in
isolation of the Dicer/ADAR1 complex from free F-Dicer or
H-ADAR1 forms (Figure S2B). We also prepared F-Dicer alone
and the F-Dicer/H-TRBP complex (Figure S2C). Dicer alone,
Dicer/TRBP, and Dicer/ADAR1 complexes were subjected to
in vitro Dicer cleavage assay using pre-let7a as substrate (Fig-
ure S3A). We also examined a 35 bp completely complementary
dsRNA containing 2 nt 30 overhangs as a different type of Dicer
substrate, which can be processed into 22 bp siRNAs and
used as an siRNA precursor (pre-siRNA) (Figure S4A). We found
that the Dicer complexed with ADAR1p150 or ADAR1p110
did cleave both pre-let-7a and pre-siRNA into mature let-7a (Fig-
ure 3A) and siRNA (Figure 3B). Furthermore, cleavage of pre-let-
7a and pre-siRNA was substantially increased (2- and 4-fold) by
both ADAR1p150 and ADAR1p110. This ADAR1 stimulation of
Dicer cleavage activities was equivalent to that of TRBP (Figures
3A and 3B). In order to understand how ADAR1 augments the
Dicer cleavage, we prepared Dicer/ADAR1 complexes consist-
ing of either ADAR1p110-EAA or ADAR1p110-E912A mutant.or one of the F-Dicer deletion mutants (bait) and the full-length H-ADAR1 (prey)
cting complexes.
The full-length F-ADAR1p110 (bait) and full-length or one of the H-ADAR1p110
d F-ADAR1/H-ADAR1 interacting complexes.
cts. Right: FLAG-IP purified proteins.
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As already mentioned, ADAR1p110-EAA cannot bind any (long
and short) dsRNA (Valente and Nishikura, 2007). ADAR1p110-
E912A has no deaminase activity because of a point mutation
of Glu912 to Ala (Lai et al., 1995). The glutamate residue is
involved in the proton transfer function of the enzyme. The
Dicer/ADAR1-E912A complex, just as the Dicer/ADAR1-WT
complex, diced pre-let-7a (3-fold) and also pre-siRNA (6-fold)
more efficiently as compared to the Dicer-alone control (Figures
3C and 3D), indicating that the ADAR1 catalytic activity is not
required for augmentation of the Dicer cleavage reaction. To
our surprise, however, we found that the complex consisting of
ADAR1-EAA mutant also increased Dicer cleavage of pre-let-
7a and pre-siRNA (Figures 3C and 3D). The result indicates
that promotion of the Dicer cleavage reaction by ADAR1 is not
mediated via direct ADAR1 binding to the substrate RNAs (pre-
miRNA or pre-siRNA) but more likely results from conformational
changes induced in Dicer by ADAR1.
To assessmore quantitatively the facilitative effects of ADAR1,
steady-state enzyme kinetics analysis was conducted using
Dicer alone and Dicer/ADAR1p110. The Dicer cleavage reaction
was carried out under multiple turnover conditions in which the
substrate concentration is in molar excess over the enzyme
(i.e., Dicer). First-order reaction rate (V0) values were obtained
through time course analysis of Dicer cleavage products of
pre-let-7a (Figure S3B) and pre-siRNA (Figure S4B). Analysis of
Michaelis-Menten plots made at various substrate concentra-
tions gave estimates of the Vmax values of the pre-let-7a cleav-
age reaction (77.3 and 307.3 pM/s; Figure 3E) and of the
pre-siRNA cleavage reaction (28.8 and 110.5 pM/s; Figure 3F)
for Dicer alone and Dicer/ADAR1, respectively, indicating that
ADAR1 increases the Vmax of the Dicer cleavage of both pre-
let-7a and pre-siRNA by 4-fold in comparison to the reaction
conducted with Dicer alone. Our results suggest that the RNA
editing enzyme ADAR1 affects the turnover rate of Dicer and
increases substantially the overall efficacy of miRNA and siRNA
processing.
ADAR1 Augments RISC Loading and Target RNA
Silencing Efficacy
We next investigated whether ADAR1 would facilitate the overall
target RNA silencing. It is possible that miRNA or siRNA cleaved
by the Dicer/ADAR1 complex may not be loaded onto a func-
tional RISC, resulting in accumulation of abortive miRNA or
siRNA. We therefore first examined the effects of ADAR1 on
loading of let-7a RNAs cleaved from pre-let-7a by the Dicer/
ADAR1 complex and subsequent silencing of its target RNA (Fig-
ure 4A, pre-miRNA dicing and RISC loading assay). Dicer, Dicer/
TRBP, or Dicer/ADAR1 was preincubated with F-Ago2 followedFigure 3. ADAR1 Augments the Dicer Cleavage Reaction Rate and Inc
(A and C) In vitro miRNA processing analysis.
(B and D) In vitro siRNA processing analysis.
(A–D) The Dicer cleavage reaction was done under single-turnover conditions. Th
radioactivity of the correctly cleaved band over that of the uncut control band. Sign
***p < 0.001). Error bars indicate SE (n = 3). See also Figure S2.
(E and F) Michaelis-Menten analysis of the pre-let-7a cleavage reaction (E). Mich
reaction was conducted under multiple-turnover conditions. V0 values were plott
also Figures S3 and S4.by addition of pre-let-7a for RISC assembly and further incu-
bated with the cognate target RNA for slicing. We found a 2.4-
fold increase in the sequence-specific Ago2 slicing of the target
RNAbyADAR1p110 (stimulation equivalent to TRBP) (Figure 4B).
Having established that let-7a RNAs diced by the Dicer/ADAR1
are functional, we next examined the effects of ADAR1 on two
separate RISC activities previously reported (Gregory et al.,
2005): loading of the single-stranded guide miRNA or loading
of the already diced miRNA duplex (Figure 4A). We found that
ADAR1 facilitates the guide RNA loading by 1.7- to 2.5-fold
(Figure 4C) and themiRNA duplex loading by 5- to 12.5-fold (Fig-
ure 4D) as compared to Ago2 alone or Dicer/Ago2. The magni-
tude of the ADAR1 effects was again very similar to that
observed with TRBP (Figures 4C and 4D). For the miRNA duplex
loading assay, we also tested two ADAR1 mutants, ADAR1-EAA
and ADAR1-E912A. These mutants exhibited activities equiva-
lent to those of wild-type ADAR1 (Figure 4D), indicating again
that neither the dsRNA-binding nor deaminase activities of
ADAR1 are required for miRNA duplex loading. Together with
the fact that ADAR1 forms the Dicer/ADAR1/Ago2 triple complex
(Figure 1D), ADAR1 appears to function in augmentation of Dicer
cleavage of pre-miRNA/pre-siRNA, RISC assembly, and loading
of miRNA, as does TRBP (Chendrimada et al., 2005; Gregory
et al., 2005).
Differentiation of ADAR1 Functions by Selective
Formation of Homodimer and Heterodimer Complexes
How does ADAR1 differentiate its two roles, one as an RNA
editing enzyme and the other as an RNAimachinery component?
SDS-PAGE and colloidal blue staining of the F-Dicer/H-
ADAR1p110 complex, which was purified through consecutive
affinity columns (Figure S2A), revealed only two bands of Dicer
and ADAR1, in approximately a 1:1 ratio (Figure S2B). We then
examined the molecular mass of the complex by fast protein
liquid chromatography size fractionation chromatography. The
Dicer/ADAR1 complex eluted 330 kDa (Figure S2D). This is
consistent with a complex containing onemolecule each of Dicer
(219 kDa) and ADAR1 (110 kDa), but not with one containing
Dicer plus an ADAR1 homodimer. As we already shown, the
ADAR1-E912A deamination defective mutant can form the Dicer
complex and function as efficient as the wild-type ADAR1 (Fig-
ures 3C and 3D). This raises the question of whether ADAR1
complexed with Dicer remains active as an editor.
To test this, we examined processing of pre-miR-151 by the
Dicer/ADAR1 heterodimer. Prior to processing of pre-miR-151
to mature miRNA, ADAR1 edits a so-called +3 site of pre-miR-
151 with 90% efficiency and the -1 site with lesser efficiency
(Figure S5A) (Kawahara et al., 2007a). We confirmed that thereases miRNA/siRNA Production
e pre-miRNA or pre-siRNA dicing efficiency was estimated by the ratio of the
ificant differences were identified by the Student’s t tests (*p < 0.05; **p < 0.01;
aelis-Menten analysis of pre-siRNA cleavage reaction (F). The Dicer cleavage
ed against substrate concentrations, leading to estimation of Vmax values. See
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Figure 4. ADAR1 Augments RISC Loading and Target RNA Silencing Efficacy
(A) RISC loading and assays using pre-let-7a, let-7a guide, or let-7a duplex RNA are schematically shown. The let-7a-5p target RNA (39 nt) was 50 32P-labeled.
Ago2 slicing of the target RNA guided by let-7a-5p would produce a 20 nt product (highlighted in red).
(B) Pre-let-7a dicing-coupled RISC loading assay; 10 nM Ago2 was used.
(C) RISC loading of let-7a guide RNA; 5 nM Ago2 was used.
(D) RISC loading of let-7a duplex RNA; 5 nM Ago2 was used.
(B–D) Sliced target RNA products were fractionated by 15% urea-PAGE (left). A quantitative summary is also shown (right). The target RNA slicing efficiency was
estimated by the ratio of the radioactivity of the correctly cleaved band over that of the uncut control band. Significant differences were identified by Student’s
t tests (*p < 0.05; **p < 0.01; ***p < 0.001). Error bars indicate SE (n = 3).
See also Figure S2.
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Dicer/ADAR1 complex efficiently diced pre-miR-151 and pro-
cesses it to mature miR-151 RNAs, whereas the ADAR1 homo-
dimer complex did not have the miRNA processing activity
(Figure S5B). Unprocessed pre-miR-151 and mature miR-151
RNAs generated by the miRNA processing assay were then
separated by gel purification and examined for A-to-I RNA edit-
ing by sequencing of the complementary DNA (cDNA) clones
derived from RT-PCR products. Neither pre-miR-151 nor mature
miR-151 RNAs were edited (Figure S5C). The results indicate
that ADAR1 complexed with Dicer acts as an RNAi machinery
component but has no A-to-I RNA editing activity because the
latter requires homodimerization of ADAR1 (Cho et al., 2003).
Our results revealed how ADAR1 differentiates its RNA editor
and RNAi functions by forming two different complexes:
ADAR1 homodimers and Dicer/ADAR1 heterodimers, respec-
tively (Figure S6).
Global Suppression of miRNA Production in ADAR1/
Mouse Embryos
To assess the in vivo effects of ADAR1 onmiRNA processing, we
investigated global miRNA expression in ADAR1/ mouse
embryos, which die around embryonic day (E) 12 (Wang et al.,
2004). Total RNA samples were prepared from ADAR1/ and
control wild-type mouse embryos collected live at E11.0 and
E11.5. Small RNAs in the miRNA size range were examined by
deep sequencing (Tables S1 and S2A). Size distribution of
miRNA reads, peaking at 22 nt, did not differ among wild-type
and ADAR1/ embryos at E11.0 and E11.5 (Figure 5A). At
E11.0, the ADAR1 knockout had no major effect on miRNA
read numbers (Table S1), but a significant decrease of miRNA
reads was observed in ADAR1/ embryos at E11.5 as
compared to control wild-type embryos (Tables S1 and S2B).
An increased number of reads was observed for other class
small RNAs of E11.5 ADAR1/ embryos, i.e., ribosomal RNA
as well as small nucleolar RNA and small-nuclear-RNA-related
small RNA, which could have affected the normalized miRNA
read numbers (Table S1). To confirm the reducedmiRNA expres-
sion in ADAR1/ embryos independently and more quantita-
tively, we determined the expression of representative miRNAs
highly expressed in wild-type embryos by quantitative RT-PCR
(qRT-PCR). We spiked a control RNA in RNA samples, which
allowed us to obtain absolute miRNA concentrations. We found
that concentrations of the miRNAs examined were indeed
reduced by 2- to 3-fold in E11.5 ADAR1/ embryos (Figure 5B),
confirming the trend predicted by deep sequencing and
reflecting more accurately the changes in miRNA. Furthermore,
qRT-PCR analysis revealed that the expression of miRNAs
dramatically increased in wild-type embryos during the half-
day period from E11.0 to E11.5 (e.g., let-7a, miR-1, and miR-
181a-5p), whereas their expression remained at the E11.0 level
in E11.5 ADAR1/ embryos (Figure 5B). Together, our findings
suggest that ADAR1 interacts with Dicer and promotes a rapid
increase of miRNA production globally around E11–E12, which
is likely essential for embryo development.
Finally, we determined the protein expression level of genes
already validated as targets of the miRNAs, which had reduced
expression (Figure 5B). We expected that reduction in the syn-
thesis of miRNAs should result in increased protein expressionlevel of their target genes. We tested FOXP1 and IRX5 as
miR-1 targets (Nasser et al., 2008; Zhao et al., 2007), Dicer as
a miR-103-3p target (Martello et al., 2010), and c-Fos as a
miR-181a target (Wu et al., 2012). As expected, increased target
gene protein levels (2- to 2.5-fold) were indeed noted in E11.5
ADAR1/ embryos (Figure 5C). Globally reduced miRNA syn-
thesis is thus likely to have significant effects on expression of
their target genes in ADAR1/ embryos.
Concomitant Upregulation of Dicer and ADAR1 in
E11-E12 Mouse Embryos
The dramatic increase of miRNA expression detected in E11.5
wild-type embryos (Figure 5B) suggests a possible upregulation
of the pre-miRNA processing machinery during this particular
period of embryo development. We therefore investigated the
expression levels of Dicer, ADAR1, and TRBP and PACT, two
dsRNA binding proteins known to enhance Dicer activity (Fig-
ure 6A) (Chakravarthy et al., 2010; Lee et al., 2006). We found
that Dicer levels indeed increased significantly at E11–E12 as
compared to those at E9–E10 (3- to 5-fold). Most importantly,
ADAR1p110 expression also increased (4- to 5-fold) con-
comitantly with Dicer (Figures 6B and 6C). Interestingly, the
ADAR1p150 inversely decreased around this time, possibly indi-
cating a special function of this ADAR1 isoform in even earlier
embryos, such as maintenance of hematopoietic stem cells, as
reported previously (Hartner et al., 2009). In contrast to the dra-
matic upregulation of Dicer and ADAR1p110, only a very modest
increase in the TRBP and PACT expression was noted at E12
(Figures 6B and 6C). Our findings suggest that a dramatic in-
crease in the pre-miRNA processing capability occurs in E11–
E12 embryos and is caused by the concomitant upregulation
of Dicer and ADAR1p110, which is likely to be required at
these stages of rapidly growing embryos. Interestingly, we found
that the Dicer protein level increased by 2-fold in E11.5
ADAR1/ embryos (Figure 5C), possibly reflecting the presence
of a feedback mechanism to attempt to compensate for the loss
of ADAR1. Alternatively, the increased expression may reflect
the reduced expression of miRNAs, which usually target Dicer
(e.g., miR-103-3p) (Figure 5C) (Martello et al., 2010). In any
case, the results suggest that the loss of ADAR1 apparently
cannot be compensated by the increased Dicer alone in upregu-
lation of miRNA synthesis. ADAR1 perhaps plays a major role
in the miRNA synthesis and miRNA-mediated gene silencing
mechanisms that may exceed that of TRBP or PACT, at least
during this period of embryonic development.
Upregulation of Genes Predicted as Targets of miRNAs
Suppressed in ADAR1/ Mouse Embryos
Having established a function of ADAR1 in themiRNA biogenesis
mechanism, we anticipated that suppression of many miRNAs
is likely to affect their target gene expression. Therefore, we
next examined the global gene expression patterns in E11.5
ADAR1/ embryos by deep sequencing analysis of the tran-
scriptome (Table S3A). A dynamic change in the gene expression
pattern (i.e., some up and others down, but not necessarily a sys-
temic shut down of all genes) was detected in E11.5 ADAR1/
embryos compared to wild-type embryos (Figure S7A; Table
S3B). We asked whether upregulation of some genes could beCell 153, 575–589, April 25, 2013 ª2013 Elsevier Inc. 583
Figure 5. Reduced Expression of miRNAs and Upregulation of Their Target Genes in ADAR1/ Mouse Embryos at E11.5
(A) Distribution of miRNA deep sequencing read lengths was compared between wild-type and ADAR1/ mouse embryos at the E11.0 and E11.5 stages. See
also Figure S7 and Tables S1, S2, and S3.
(B) Quantitation of select miRNAs expressed in E11.0 and E11.5 embryos. A spike control, 23 1010 copies of a chemically synthesized RNA, was added to the RT
reaction mixture. Quantitative PCR was conducted in quadruplicate. The relative miRNA expression level standardized by the spiked RNA is presented as the
expression level relative to that of the wild-type embryo at E11.0. Significant differences were identified by Student’s t tests (*p < 0.05; **p < 0.01; ***p < 0.001).
Error bars indicate SD (n = 5).
(C) Increased protein expression of the genes targeted by the miRNAs reduced in ADAR1/ embryos. Immunoblotting analysis of select target gene levels
in E11.5 embryos (left) and a quantitative summary (right) are shown. Significant differences were identified by Student’s t tests (**p < 0.01). Error bars indicate
SD (n = 5).
See also Figure S7.
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Figure 6. Dicer and ADAR1 Are Rapidly
Induced in E11–E12 Stage Embryos
(A) The domain structures of two ADAR1 isoforms,
TRBP, and PACT.
(B) Immunoblotting analysis of proteins involved in
the pre-miRNA processing mechanism. Wild-type
mouse embryos were collected live at various
embryonic stages (E9.0–E12.0), and the extracted
protein was fractionated by 4%–15% SDS-PAGE
and tested for immunoblotting analysis.
(C) Quantitative summary of immunoblotting
analysis results. The relative expression level was
normalized by b-actin and presented as the
expression level relative to that of the E9.0
embryo. Significant differences were identified by
Student’s t tests (*p < 0.05; ***p < 0.001). Error bars
indicate SD (n = 4).the result of downregulation of their relevant miRNAs. We first
identified the miRNAs for which read numbers were reduced
more than 4-fold (Table S2B) and the gene transcripts for which
expression was upregulated more than 2-fold in E11.5
ADAR1/ embryos (Figures S7B and S7C; Table S3B). In silico
target prediction analysis revealed that a large fraction of the up-
regulated genes were indeed targets of the downregulated miR-
NAs (miRNA-target pairs) (Figure S7A; Table S3C).We found that
these genes are enriched in many different functions and path-
ways such as cell death, cell proliferation, hematopoiesis, and
cardiovascular system development (Table S3C). We already
showed upregulation of select target gene protein expression
(Figure 5D). Together, our results indicate that ADAR1 plays an
important role in facilitating Dicer cleavage and increasing the
expression of miRNA, which in turn controls the coordinated
gene expression involved in many different biological functions
and pathways during development.
Effects of ADAR1 on Synthesis of miRNAs in Cultured
Cells
Having established ADAR1 RNAi functions in developing mouse
embryos, we next examined the effects of ADAR1 on miRNA
synthesis in cultured cells. We carried out single or combination
knockdowns of ADAR1, TRBP, and PACT (Figure 7A) and quan-
titated select miRNA expression levels in HeLa cells (Figure 7B).
The four miRNAs monitored have no A-to-I editing sites (Kawa-
hara et al., 2008), excluding the possibility of their expression
being affected by the ADAR1 editing function. We found that
PACT knockdown had very little effect on the monitored miRNA
expression, whereas TRBP knockdown reduced miRNA levelsCell 153, 575–5by 40%–70%, as reported previously
(Koscianska et al., 2011). ADAR1 knock-
down caused a significant reduction
(30%–40% reduction), slightly less than
TRBP. Knockdown of both ADAR1 and
TRBP generated an additional 10%–
20% suppression effect as compared
to TRBP single knockdown (Figure 7B).
We investigated the effects of ADAR1
on miRNA synthesis also by deepsequencing of miRNAs expressed in HeLa cells treated for
ADAR1 knockdown (Table S4). A global reduction of miRNA
synthesis was noted in ADAR1 knockdown HeLa cells as
compared to the control siRNA-treated HeLa cells. The extent
of the reduction was similar to that expected from the qRT-
PCR analysis done for selected miRNAs. Our results indicate
that ADAR1 does have an impact onmiRNA synthesis in cultured
cells.
DISCUSSION
The antagonistic interaction of A-to-I editing with RNAi (i.e.,
the competitive inhibition of the RNAi pathway by A-to-I edit-
ing of dsRNA substrates) has been reported previously. A-to-I
editing of these dsRNAs results in their structural alterations
(reduction in double strandedness) and reduced production of
end-siRNAs (Wu et al., 2011) or functional miRNAs (Iizasa
et al., 2010; Kawahara et al., 2007a, 2007b, 2008; Yang et al.,
2006), leading to suppression of the RNAi efficacy (Figure S6,
left).
In this study, we demonstrated the presence of a completely
different type of interaction (stimulative interaction) between
RNA editing and RNAi mechanisms through the formation of
Dicer/ADAR1 complexes (Figure S6, right). Mass spectrometric
analyses of the proteins associated with Dicer have previously
identified ADAR1 as one of putative Dicer-interacting proteins,
although the mode and biological significance of their associa-
tion was not investigated (Landthaler et al., 2008). Size fraction-
ation column chromatography analysis of the Dicer/ADAR1
complex indicated that monomeric ADAR1 associates with Dicer89, April 25, 2013 ª2013 Elsevier Inc. 585
Figure 7. Effects of ADAR1 on RNAi Efficacy in HeLa Cells
(A) Immunoblotting analysis of ADAR1, TRBP, and PACT protein levels in HeLa
cells 72 hr after transfection with ADAR1, TRBP, PACT, and ADAR1/TRBP
siRNAs.
(B) Quantification of selected miRNA expression levels by qRT-PCR. The
relative expression level was normalized by b-actin and presented as the
expression level relative to that of HeLa cells treated with control siRNA.
Significant differences were identified by Student’s t tests (*p < 0.05;
**p < 0.01***p < 0.001). Error bars indicate SD (n = 4).
See also Table S4.in a 1:1 ratio. Most importantly, our studies have demonstrated
that ADAR1 in the complex positively controls the activity of
Dicer by increasing Vmax of the pre-miRNA or pre-siRNA cleav-
age reaction, thereby generating significantly more mature
miRNAs or siRNAs. We have also demonstrated that miRNAs586 Cell 153, 575–589, April 25, 2013 ª2013 Elsevier Inc.generated by the Dicer/ADAR1 complex are functional; i.e.,
they are loaded onto Ago2/RISC and capable of silencing the
target RNA (Figure S6, right).
Involvement of certain dsRBDs in RNA-binding-independent
protein-protein interaction has been reported (Haase et al.,
2005; Hitti et al., 2004). We previously showed that the second
dsRBD of ADAR1, but not the first or third, is dispensable for
A-to-I editing activity of ADAR1 (Lai et al., 1995). Here, we
showed that the second dsRBD of ADAR1 is required for its
RNA-binding-independent interaction with Dicer. Both the
DUF283 domain and the N-terminal half of the DEAD-box RNA
helicase domain of Dicer seem to be involved in the interaction
with ADAR1. The very similar N-terminal region of Dicer has
been reported to be involved in the RNA-binding-independent
Dicer/TRBP interaction via the third dsRBD of TRBP (Daniels
et al., 2009; Haase et al., 2005), revealing that ADAR1 and
TRBP utilize the same DEAD-box RNA helicase domain for
their interaction with Dicer. Recent computational studies
revealed a significant structural similarity of the DUF283 domain
to the dsRBD domain (abbba folding) (Dlakic, 2006). The involve-
ment of the DUF283 domain in the Dicer/ADAR1 complex, but
not in the Dicer/TRBP complex, may be related to the fact that
the second dsRBD (dsRBD2) of ADAR1 is utilized instead of
the third dsRBD (dsRBD3) being used by TRBP (Figure 6A), lead-
ing to a different conformational change induced in Dicer by
ADAR1. The exact function of the DUF283 domain uniquely
involved in the Dicer/ADAR1 complex formation remains to be
established.
The pre-miRNA cleavage and RISC loading experiments using
ADAR1 mutants defective in dsRNA binding or A-to-I deamina-
tion revealed that dsRNA binding and deaminase activities of
ADAR1 are not required for the mechanism that increases the
rate of pre-miRNA cleavage or for the mechanism that facilitates
RISC loading. We demonstrated that ADAR1 in the Dicer com-
plex is not competent for A-to-I editing. Thus, augmentation of
the Dicer activity by the ADAR1-deamination-defective mutant
was anticipated. However, it was surprising to find that the
dsRNA-binding-defective ADAR1 mutant facilitated both pre-
miRNA cleavage and RISC loading steps just as well as wild-
type ADAR1, indicating that no direct binding of ADAR1 to
pre-miRNAs or already diced miRNA duplexes is involved in
the Dicer activity augmentation mechanisms. TRBP complexes
with Dicer via its third dsRNA binding domain (dsRBD3) and in-
creases the Dicer cleavage activity (Daniels et al., 2009; Haase
et al., 2005), but deletion of the other two dsRBDs (dsRBD1
and dsRBD2) abolished its Dicer augmentation activity, leading
to proposal of a model in which direct binding of TRBP to
pre-miRNA substrates via dsRBD1 and dsRBD2 increases the
initial substrate recognition rate (Chakravarthy et al., 2010).
However, the direct binding of TRBPwithin the Dicer/TRBP com-
plex to pre-miRNAs has never been demonstrated (Chakravar-
thy et al., 2010). In view of the dsRNA-binding-independent
ADAR1 effects, conformational changes induced in Dicer by
ADAR1 are likely to underlie the mechanism that upregulates
the Dicer function. TRBP has been reported to increase signifi-
cantly the stability of Dicer (Chendrimada et al., 2005). We found
an increased Dicer protein level in E11.5 ADAR1/ embryos as
compared to wild-type embryos (Figure 5C), which rules out any
role for ADAR1 in Dicer stabilization. Interestingly, the DEAD-box
RNA helicase domain has been reported to autoinhibit the
catalytic efficiency of Dicer (Ma et al., 2008), suggesting the
possibility that ADAR1 stimulates the Dicer activity (pre-miRNA
cleavage and RISC loading) through its binding to this region,
releasing the autoinhibitory effects of the DEAD-box RNA heli-
case domain.
It was surprising to find that ADAR1, with its well-known func-
tion in the A-to-I editing mechanism, has a completely different
persona as an RNAi-stimulating regulator like TRBP and PACT.
The formation of a homodimer complex of ADAR1 mediated
via the third dsRBD (Figure 2D) is essential for its enzymatic
activity (Cho et al., 2003), and the monomeric ADAR1 in the
Dicer/ADAR1 complex thus lacks A-to-I deamination activities,
as we demonstrated in this study. Thus, ADAR1 seems to
differentiate its two roles in the A-to-I RNA editing and RNAi
mechanisms by forming two different types of complexes:
ADAR1 homodimers andDicer/ADAR1 heterodimers (Figure S6).
However, we do not know the exact mechanism that determines
the balance of the two functions. Because the RNAi function of
ADAR1 is exerted in the cytoplasm, cytoplasmic versus nuclear
distribution and concentration of ADAR1 as well as concentra-
tions of TRBP or PACT in developing embryos, various tissues,
and cell lines may be parameters that determine the ratio of
ADAR1 homodimer and Dicer/ADAR1 heterodimer formation.
We previously reported that editing occurs in approximately
20% of pri-miRNAs in human brains and often inhibits their pro-
cessing tomaturemiRNAs (Kawahara et al., 2008). Despite a sig-
nificant increase in the ADAR1 expression level (Figures 6B and
6C), we found that A-to-I editing of pri-miRNAs is very limited in
E11–E12 wild-type mouse embryos (Y. Kawahara and K.N.,
unpublished data). Thus, the function of ADAR1 may be more
skewed toward an RNAi regulator than an RNA editor in growing
embryos (Figure S6).
Inactivation of the mouse ADAR1 gene results in widespread
apoptosis and death of embryos at around E12 (Wang et al.,
2004). Aberrant activation of interferon signaling pathways
has been suggested as the underlying mechanism (Hartner
et al., 2009). In contrast to the severe ADAR1/ mouse pheno-
type, only mild phenotypic alterations (i.e., growth retardation
and male sterility for TRBP/ mutant mice [Zhong et al.,
1999] and defective ear development and hearing loss for
PACT/ mice [Rowe et al., 2006]) have been reported. These
results may indicate a more important contribution of ADAR1
than TRBP and PACT in the miRNA-mediated RNAi, espe-
cially in E11–E12 embryos. The expression of ADAR1 (p110
isoform) is rapidly induced around this time, concomitantly
with Dicer, in contrast to the delayed and modest increase of
TRBP and PACT expression revealed in this study (Figures
6B and 6C). In ADAR1/ embryos, the rapid and significant
upregulation of miRNA production cannot occur because of
the lack of formation of the Dicer/ADAR1 complex. This seems
to result in the dysregulated expression of many genes that are
otherwise repressed by these miRNAs during normal develop-
ment of wild-type embryos (Figure S7). It is tempting to specu-
late that a deficiency in the RNAi function rather than the RNA
editing function of ADAR1 underlies the ADAR1/ mouse
phenotype.EXPERIMENTAL PROCEDURES
Mice
The ADAR1/ mouse line (Wang et al., 2004), backcrossed more than ten
times to C57BL/6J mice, was used for small RNA sequencing (small RNA-
seq), RNA sequencing (RNA-seq), and qRT-PCR analyses as well as protein
expression analyses. Animal protocols for breeding and preparation of
embryonic RNAand protein samples were approved by the Institutional Animal
Care and Use Committee of The Wistar Institute and performed in accordance
with the US National Institutes of Health Guidelines.
Dicer Cleavage Assay
The pre-let-7a RNA substrate for the Dicer cleavage assay was synthesized by
in vitro transcription of a plasmid template containing a double ribozyme sys-
tem (plasmid, a gift from Dr. J. Doudna) (Ferre´-D’Amare´ and Doudna, 1996).
The 35 bp duplex RNA used as a pre-siRNA substrate was made by annealing
pre-siRNA sense and antisense RNAs, which were synthesized by Integrated
DNA Technologies. Pre-let-7a and the sense strand of pre-siRNA were 50 end-
labeled using T4 polynucleotide kinase (New England Biolabs) and (g-32P)-
ATP. The sequences of the substrates were as follows: pre-let-7a, 50-UGAG
GUAGUAGGUUGUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAAC
UAUACAAUCUACUGUCUUACC-30; pre-siRNA sense, 50-UGAGGUAGUAG
GUUGUAUAGUUUGAAAGUUCACGAUU-30; pre-siRNA antisense, 50-UCGU
GAACUUUCAAACUAUACAACCUACUACCUCAAA-30.
In vitro Dicer cleavage assays were done in a 40 ml reaction mixture con-
taining 20 mM PIPES (pH 6.5), 1.5 mM MgCl2, 80 mM NaCl, 1 mM dithio-
threitol (DTT), 10% glycerol, 5 nM Dicer, and 50 end-32P-labeled substrate
(pre-let-7a or pre-siRNA) at concentrations of 25, 50, 75, 100, 150, and
200 nM. Reactions were incubated at 37C, and 5 ml aliquots were taken
after 0, 2, 5, 10, 20, and 40 min. The reactions were stopped by adding
1.2 vol Gel Loading Buffer II (Ambion). After heating at 75C for 10 min,
the samples were analyzed by 15% urea-PAGE and quantified using
MolecularDynamics and ImageQuant (GE Healthcare). Initial velocities (vo)
at each substrate concentration (S) were determined by linear regression,
using Kaleidagraph (Synergy Software). Vmax along with SEs were calculated
by fitting to the Michaelis-Menten equation, vo = (Vmax 3 S)/(Km + S), using
Graphpad Prism (Graphpad Software).
Pre-miRNA Cleavage-Coupled RISC Loading Assay
A 7 ml reaction mixture in 20 mM PIPES (pH 6.5), 1.5 mMMgCl2, 80 mM NaCl,
1 mM DTT, and 10% glycerol containing 10 fmol F-Dicer, F-Dicer/H-TRBP, or
F-Dicer/H-ADAR1 and 100 fmol F-Ago2 was preincubated at 4C for 30 min.
Subsequently, 100 fmol human pre-let-7a-1 was added to the reactions and
further incubated for dicing of pre-let-7a-1 and loading of let-7a-1 to
F-Ago2/RISC at 37C for 10 min. The target RNA cleavage reaction in a
10 ml reaction mixture was mixed with 10 fmol of 50 end-32P-labeled let-7a-1
target RNA and 2 U/ml RNasin (Promega) and incubated at 37C for 10 min.
The reactions were stopped by adding 1.2 vol Gel Loading Buffer II (Ambion).
RISC loading products (32P-labeled sliced target RNAs) were analyzed by 15%
urea-PAGE and quantified using MolecularDynamics. The sequences of the
substrates were as follows: human pre-let-7a-1, 50-UGAGGUAGUAGGUU
GUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAACUAUACAAUCU
ACUGUCUUUC-30 (Dharmacon); let-7a-1 target RNA, 50-GUAUCAACCACU
AUACAACCUACUACCUCAACGUUCAAU-30 (Integrated DNA Technologies).
Assay for RISC Loading of Single-Stranded GuidemiRNA andmiRNA
Duplexes
RISC loading of single-stranded guide let-7a or let-7a RNA duplex was
done exactly as described for the pre-miRNA dicing-coupled RISC loading
assay, except as follows. Human let-7a-1 or let-7a-1 duplex (100 fmol)
was used for the reaction. An additional incubation for loading of let-7a-1
or let-7a-1 duplex to F-Ago2/RISC was done at 30C for 30 min. The
target RNA slicing reaction (10 ml) was incubated with 10 fmol of 50 end-32P-
labeled let-7a-1 target RNA and 4 U/ml RNasin (Promega) at 30C for
90 min. The reaction was stopped by adding Proteinase K (Roche) to
1 mg/ml followed by incubation at 37C for 30 min prior to phenol/chloro-
form/isopropanol extraction. Let-7a-1 RNA duplex was made by annealingCell 153, 575–589, April 25, 2013 ª2013 Elsevier Inc. 587
let-7a S22 (50-UGAGGUAGUAGGUUGUAUAGUU-30) and let-7a A21 (50-CUA
UACAAUCUACUGUCUUUC-30) synthesized at Integrated DNA Technologies.
Small RNA-Seq and RNA-Seq and Bioinformatics Data Analysis
Procedures for small RNA-seq and RNA-seq and bioinformatics data analysis
are described in the Extended Experimental Procedures.
Statistical Analysis
Experiments were run in triplicate or quadruplicate and repeated in a minimum
of three independent trials. Image quantitation was done using ImageQuant
image analysis software (GE Healthcare). Data are presented as means
±SD. Two-tailed t tests were conducted where the minimum level of signifi-
cance was p < 0.05.
ACCESSION NUMBERS
The small RNA-seq and RNA-seq data from this study have been sub-
mitted to the NCBI Gene Expression Omnibus under series accession
number GSE43192 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE43192).
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org/10.1016/j.cell.2013.03.024.
ACKNOWLEDGMENTS
We thank Jennifer A. Doudna for the pre-let-7a template plasmid, Zissimos
Mourelatos for discussion on RISC loading analysis, and John M. Murray
for discussion on enzyme kinetics analysis and also critical reading of the
manuscript. This work was supported by grants from the National Institutes
of Health (GM040536, HL070045, and HL099342), the Ellison Medical
Foundation (AG-55-2281-09), and the Commonwealth Universal Research
Enhancement Program, Pennsylvania Department of Health (to K.N.).
B.-E.W. is a recipient of a University of Pennsylvania, Vagelos scholarship.
M.S. is supported in part by a fellowship from the Japan Society for the Pro-
motion of Science (JSPS 2010-22). We are also grateful for services provided
by the Protein Expression, Genomics, and Bioinformatics Shared Facilities of
The Wistar Cancer Center, which are supported by the National Cancer Insti-
tute (P30 CA010815).
Received: July 7, 2012
Revised: October 27, 2012
Accepted: March 13, 2013
Published: April 25, 2013
REFERENCES
Chakravarthy, S., Sternberg, S.H., Kellenberger, C.A., and Doudna, J.A.
(2010). Substrate-specific kinetics of Dicer-catalyzed RNA processing.
J. Mol. Biol. 404, 392–402.
Chendrimada, T.P., Gregory, R.I., Kumaraswamy, E., Norman, J., Cooch, N.,
Nishikura, K., and Shiekhattar, R. (2005). TRBP recruits the Dicer complex to
Ago2 for microRNA processing and gene silencing. Nature 436, 740–744.
Cho, D.S., Yang, W., Lee, J.T., Shiekhattar, R., Murray, J.M., and Nishikura, K.
(2003). Requirement of dimerization for RNA editing activity of adenosine
deaminases acting on RNA. J. Biol. Chem. 278, 17093–17102.
Daniels, S.M., Melendez-Pen˜a, C.E., Scarborough, R.J., Daher, A., Christen-
sen, H.S., El Far, M., Purcell, D.F., Laine´, S., and Gatignol, A. (2009). Charac-
terization of the TRBP domain required for dicer interaction and function in
RNA interference. BMC Mol. Biol. 10, 38.
Dlakic, M. (2006). DUF283 domain of Dicer proteins has a double-stranded
RNA-binding fold. Bioinformatics 22, 2711–2714.588 Cell 153, 575–589, April 25, 2013 ª2013 Elsevier Inc.Ferre´-D’Amare´, A.R., and Doudna, J.A. (1996). Use of cis- and trans-
ribozymes to remove 50 and 30 heterogeneities from milligrams of in vitro
transcribed RNA. Nucleic Acids Res. 24, 977–978.
Fritz, J., Strehblow, A., Taschner, A., Schopoff, S., Pasierbek, P., and Jantsch,
M.F. (2009). RNA-regulated interaction of transportin-1 and exportin-5 with the
double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling
of ADAR1. Mol. Cell. Biol. 29, 1487–1497.
Gregory, R.I., Chendrimada, T.P., Cooch, N., and Shiekhattar, R. (2005).
Human RISC couples microRNA biogenesis and posttranscriptional gene
silencing. Cell 123, 631–640.
Haase, A.D., Jaskiewicz, L., Zhang, H., Laine´, S., Sack, R., Gatignol, A., and
Filipowicz,W. (2005). TRBP, a regulator of cellular PKR andHIV-1 virus expres-
sion, interacts with Dicer and functions in RNA silencing. EMBO Rep. 6,
961–967.
Hartner, J.C., Schmittwolf, C., Kispert, A., Mu¨ller, A.M., Higuchi, M., and
Seeburg, P.H. (2004). Liver disintegration in themouse embryo caused by defi-
ciency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 279, 4894–4902.
Hartner, J.C., Walkley, C.R., Lu, J., and Orkin, S.H. (2009). ADAR1 is essential
for the maintenance of hematopoiesis and suppression of interferon signaling.
Nat. Immunol. 10, 109–115.
Hitti, E.G., Sallacz, N.B., Schoft, V.K., and Jantsch, M.F. (2004). Oligomeriza-
tion activity of a double-stranded RNA-binding domain. FEBS Lett. 574,
25–30.
Hood, J.L., and Emeson, R.B. (2012). Editing of neurotransmitter receptor and
ion channel RNAs in the nervous system. Curr. Top. Microbiol. Immunol. 353,
61–90.
Iizasa, H., Wulff, B.E., Alla, N.R., Maragkakis, M., Megraw, M., Hatzigeorgiou,
A., Iwakiri, D., Takada, K., Wiedmer, A., Showe, L., et al. (2010). Editing of
Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting
and consequently affects viral latency. J. Biol. Chem. 285, 33358–33370.
Kawahara, Y., Zinshteyn, B., Chendrimada, T.P., Shiekhattar, R., and Nishi-
kura, K. (2007a). RNA editing of the microRNA-151 precursor blocks cleavage
by the Dicer-TRBP complex. EMBO Rep. 8, 763–769.
Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A.G.,
and Nishikura, K. (2007b). Redirection of silencing targets by adenosine-to-
inosine editing of miRNAs. Science 315, 1137–1140.
Kawahara, Y., Megraw, M., Kreider, E., Iizasa, H., Valente, L., Hatzigeorgiou,
A.G., and Nishikura, K. (2008). Frequency and fate of microRNA editing in
human brain. Nucleic Acids Res. 36, 5270–5280.
Koscianska, E., Starega-Roslan, J., and Krzyzosiak, W.J. (2011). The role of
Dicer protein partners in the processing of microRNA precursors. PLoS ONE
6, e28548.
Krol, J., Loedige, I., and Filipowicz, W. (2010). The widespread regulation of
microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597–610.
Lai, F., Drakas, R., and Nishikura, K. (1995). Mutagenic analysis of double-
stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of
glutamate-gated ion channel transcripts. J. Biol. Chem. 270, 17098–17105.
Landthaler, M., Gaidatzis, D., Rothballer, A., Chen, P.Y., Soll, S.J., Dinic, L.,
Ojo, T., Hafner, M., Zavolan, M., and Tuschl, T. (2008). Molecular characteriza-
tion of human Argonaute-containing ribonucleoprotein complexes and their
bound target mRNAs. RNA 14, 2580–2596.
Lee, Y., Hur, I., Park, S.Y., Kim, Y.K., Suh, M.R., and Kim, V.N. (2006). The role
of PACT in the RNA silencing pathway. EMBO J. 25, 522–532.
Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J.,
Hammond, S.M., Joshua-Tor, L., and Hannon, G.J. (2004). Argonaute2 is the
catalytic engine of mammalian RNAi. Science 305, 1437–1441.
Ma, E., MacRae, I.J., Kirsch, J.F., and Doudna, J.A. (2008). Autoinhibition of
human dicer by its internal helicase domain. J. Mol. Biol. 380, 237–243.
Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S.,
Enzo, E., Guzzardo, V., Rondina, M., Spruce, T., et al. (2010). A MicroRNA
targeting dicer for metastasis control. Cell 141, 1195–1207.
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., and
Tuschl, T. (2004). Human Argonaute2 mediates RNA cleavage targeted by
miRNAs and siRNAs. Mol. Cell 15, 185–197.
Nasser, M.W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S.,
Wang, B., Suster, S., Jacob, S.T., and Ghoshal, K. (2008). Down-regulation
of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property
of lung cancer cells and their sensitization to doxorubicin-induced apoptosis
by miR-1. J. Biol. Chem. 283, 33394–33405.
Nishikura, K. (2006). Editor meets silencer: crosstalk between RNA editing and
RNA interference. Nat. Rev. Mol. Cell Biol. 7, 919–931.
Nishikura, K. (2010). Functions and regulation of RNA editing by ADAR
deaminases. Annu. Rev. Biochem. 79, 321–349.
Ramaswami, G., Lin, W., Piskol, R., Tan, M.H., Davis, C., and Li, J.B. (2012).
Accurate identification of human Alu and non-Alu RNA editing sites. Nat.
Methods 9, 579–581.
Rowe, T.M., Rizzi, M., Hirose, K., Peters, G.A., and Sen, G.C. (2006). A role of
the double-stranded RNA-binding protein PACT in mouse ear development
and hearing. Proc. Natl. Acad. Sci. USA 103, 5823–5828.
Scadden, A.D. (2005). The RISC subunit Tudor-SN binds to hyper-edited
double-stranded RNA and promotes its cleavage. Nat. Struct. Mol. Biol. 12,
489–496.
Valente, L., and Nishikura, K. (2007). RNA binding-independent dimerization of
adenosine deaminases acting on RNA and dominant negative effects of
nonfunctional subunits on dimer functions. J. Biol. Chem. 282, 16054–16061.Wang, Q., Miyakoda,M., Yang,W., Khillan, J., Stachura, D.L., Weiss, M.J., and
Nishikura, K. (2004). Stress-induced apoptosis associated with null mutation
of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 279, 4952–4961.
Wu, D., Lamm, A.T., and Fire, A.Z. (2011). Competition between ADAR and
RNAi pathways for an extensive class of RNA targets. Nat. Struct. Mol. Biol.
18, 1094–1101.
Wu, C., Gong, Y., Yuan, J., Zhang, W., Zhao, G., Li, H., Sun, A., Zou, Y., and
Ge, J.; KaiHu. (2012). microRNA-181a represses ox-LDL-stimulated inflam-
matory response in dendritic cell by targeting c-Fos. J. Lipid Res. 53, 2355–
2363.
Yang,W., Chendrimada, T.P., Wang, Q., Higuchi, M., Seeburg, P.H., Shiekhat-
tar, R., and Nishikura, K. (2006). Modulation of microRNA processing and
expression through RNA editing by ADAR deaminases. Nat. Struct. Mol.
Biol. 13, 13–21.
Zhao, Y., Ransom, J.F., Li, A., Vedantham, V., von Drehle, M., Muth, A.N.,
Tsuchihashi, T., McManus, M.T., Schwartz, R.J., and Srivastava, D. (2007).
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice
lacking miRNA-1-2. Cell 129, 303–317.
Zhong, J., Peters, A.H., Lee, K., and Braun, R.E. (1999). A double-stranded
RNAbinding protein required for activation of repressedmessages inmamma-
lian germ cells. Nat. Genet. 22, 171–174.Cell 153, 575–589, April 25, 2013 ª2013 Elsevier Inc. 589
